Evidence map›Paper›PMID 26359453›Full record

ArticleCancer research2015

A systematic analysis reveals heterogeneous changes in the endocytic activities of cancer cells.

Sarah R Elkin, Nawal Bendris, Carlos R Reis, Yunyun Zhou, Yang Xie, Kenneth E Huffman, John D Minna, Sandra L Schmid

Abstract read
In one paragraph

Article in Cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. DNA Origami-Cyanine Nanocomplex for Precision Imaging of KRAS-Mutant Pancreatic Cancer Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Cargo-specific effects of hypoxia on clathrin-mediated trafficking.Pflugers Archiv : European journal of physiology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sarah R ElkinDepartment of Cell Biology, UT Southwestern Medical Center, Dallas, Texas.
Nawal BendrisDepartment of Cell Biology, UT Southwestern Medical Center, Dallas, Texas.
Carlos R ReisDepartment of Cell Biology, UT Southwestern Medical Center, Dallas, Texas.
Yunyun ZhouDepartment of Clinical Science and Quantitative Biomedical Research Center (QBRC), UT Southwestern Medical Center, Dallas, Texas.
Yang XieDepartment of Clinical Science and Quantitative Biomedical Research Center (QBRC), UT Southwestern Medical Center, Dallas, Texas.
Kenneth E HuffmanThe Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas.
John D MinnaThe Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas. Departments of Internal Medicine and Pharmacology, UT Southwestern Medical Center, Dallas, Texas.
Sandra L SchmidDepartment of Cell Biology, UT Southwestern Medical Center, Dallas, Texas. Sandra.Schmid@utsouthwestern.edu.
Southwestern Medical Center · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
EARLY STEPS IN RECEPTOR-MEDIATED ENDOCYTOSISR01GM042455 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI METTLEN, MARCEL BERNARD · 1989 to 2020
$8.2M
MECHANISMS OF DRUG ACTION AND DISPOSITIONT32GM007062 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI MANGELSDORF, DAVID J · 1985 to 2020
$7.4M
Request for administrative supplement to Parent R01 GM073165 entitled "Mechanisms regulating clathrin-mediated endocytosis"R01GM073165 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI METTLEN, MARCEL BERNARD · 2006 to 2022
$6.8M
Mechanisms of Disease & Translational ScienceT32GM109776 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI YIN, HELEN L · 2014 to 2018
$573k
Howard Hughes Medical Institute 56006776NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA070907NCI NIH HHS P50CA70907NCI NIH HHS R01CA15230NIGMS NIH HHS 1T32GM10977601NIGMS NIH HHS GM00706240NIGMS NIH HHS R01 GM042455NIGMS NIH HHS R01GM042455NIGMS NIH HHS R01 GM073165NIGMS NIH HHS R01GM073165NIGMS NIH HHS T32 GM007062NIGMS NIH HHS T32 GM109776
6 · The paper itself

Abstract

Metastasis is a multistep process requiring cancer cell signaling, invasion, migration, survival, and proliferation. These processes require dynamic modulation of cell surface proteins by endocytosis. Given this functional connection, it has been suggested that endocytosis is dysregulated in cancer. To test this, we developed In-Cell ELISA assays to measure three different endocytic pathways: clathrin-mediated endocytosis, caveolae-mediated endocytosis, and clathrin-independent endocytosis and compared these activities using two different syngeneic models for normal and oncogene-transformed human lung epithelial cells. We found that all endocytic activities were reduced in the transformed versus normal counterparts. However, when we screened 29 independently isolated non-small cell lung cancer (NSCLC) cell lines to determine whether these changes were systematic, we observed significant heterogeneity. Nonetheless, using hierarchical clustering based on their combined endocytic properties, we identified two phenotypically distinct clusters of NSCLCs. One co-clustered with mutations in KRAS, a mesenchymal phenotype, increased invasion through collagen and decreased growth in soft agar, whereas the second was enriched in cells with an epithelial phenotype. Interestingly, the two clusters also differed significantly in clathrin-independent internalization and surface expression of CD44 and CD59. Taken together, our results suggest that endocytotic alterations in cancer cells that affect cell surface expression of critical molecules have a significant influence on cancer-relevant phenotypes, with potential implications for interventions to control cancer by modulating endocytic dynamics.

Indexed as

EndocytosisCarcinoma, Non-Small-Cell LungCaveolaeCD59 AntigensCell AdhesionCell Line, TumorCell MembraneCell MovementCell ProliferationClathrinCollagenHumansHyaluronan ReceptorsLung NeoplasmsNeoplasm InvasivenessProto-Oncogene Proteins p21(ras)CD44 protein, humanCD59 AntigensCD59 protein, humanClathrinCollagenHyaluronan ReceptorsKRAS protein, humanProto-Oncogene Proteins p21(ras)

Identifiers

PMID26359453
PMCPMC4802864
OpenAlexW1935374681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.